Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03119051
Other study ID # RuijinHSH
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 15, 2017
Est. completion date May 2021

Study information

Verified date August 2020
Source Ruijin Hospital
Contact Sheng-Di Chen
Phone 86-21-6445-4473
Email chen_sd@medmail.com.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the effects of "computerized cognitive training" and "cognitive training plus exercise training" on different cognitive domains in mild cognitive impairment (MCI) patients. Patients will be randomized into the computerized training group, cognitive training plus exercise training group and the control group.


Description:

Mild cognitive impairment (MCI) is an early stage of Alzheimer Disease (AD). Increasing evidence has indicated that cognitive trainings improve cognition functions of MCI patients in multiple cognitive domains, making it a promising therapy for MCI. However, the effect of long-time training has not been widely explored. It is also necessary to evaluate the extent of its function in reducing the conversion rate from MCI to AD.


Recruitment information / eligibility

Status Recruiting
Enrollment 250
Est. completion date May 2021
Est. primary completion date March 2021
Accepts healthy volunteers No
Gender All
Age group 50 Years to 85 Years
Eligibility Inclusion Criteria:

- Male or female, aged 50-85;

- MCI diagnosed according to the National Institute on Aging-Alzheimer's Association (NIA-AA) workgroups[1];

- 24=Mini-Mental State Examination (MMSE) =28;

- The Hamilton Depression Scale/17-item (HAMD) score =10;

- Not on medication for dementia;

- MRI T2 weighted image (T2WI) scan: aged =70 , Fazeca scale for White Matter lesions rating level=1; >70 years, white matter damage rating scale =2. The number of lacunar infarcts larger than 2 cm in diameter =2. No infarcts in hypothalamus, entorhinal cortex, para-hypothalamus, cortical and subcortical cavity infarction near gray matter nuclei. The medial temporal lobe atrophy (MTA) score: Grade II or above.

- Accompanied by reliable caregivers (at least intensive contact of 4 days every week and 2 hours every day) who are expected to participate in the follow-up visits and provide useful information for scores of scales like ADCS-ADL;

- Education level: primary school (grade 6) or above.

- Expected good compliance with the therapy and follow-up. Each patient gives a written informed consent, and the study has been approved by Ruijin Hospital's ethical committees.

Exclusion Criteria:

- Cognitive decline caused by other diseases (cerebrovascular disease, central nervous system infections, Parkinson's disease, metabolic encephalopathy, intracranial space-occupying lesions, deficiency of folic acid/vitamin B12 and hypothyroidism);

- Medical history of other neurological disorders (including stroke, Neuromyelitis optica, Parkinson's disease, epilepsy, etc.);

- Psychiatric disorders defined by (Diagnostic and Statistical Manual of Mental Disorders) DSM-IV criteria;

- Unstable or severe disease of heart, lung, liver, kidney or hematopoietic system;

- History of alcohol or drug abuse;

- Participation in other clinical trial less than 30 days before the screening of this study;

- Inability to complete the study.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Online cognitive training
A variety of cognitive domains will be involved in the training including memory, calculation, attention, visuospatial and executive skills. The difficulty level of each game will be adjusted automatically according to patients' last training results so that patients' correction rate will be kept between 70% and 80%.
Cognitive training plus physical exercise
Online cognitive training A variety of cognitive domains will be involved in the training including memory, calculation, attention, visuospatial and executive skills. The difficulty level of each game will be adjusted automatically according to patients' last training results so that patients' correction rate will be kept between 70% and 80%. Physical Exercise Tai Chi Training:a teacher will give two 60-min lessons per week. Participants will play Tai Chi in the lessons, following teacher's instruction.

Locations

Country Name City State
China Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine Shanghai Shanghai

Sponsors (4)

Lead Sponsor Collaborator
Ruijin Hospital Huashan Hospital, RenJi Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of AD The 3-year incidence of AD in each group will be compared. 12 months
Secondary The global cognitive function of MCI patients Alzheimer disease assessment scale (ADAS-Cog) will be used to assess the global cognitive performance of MCI patients 6 months
Secondary Memory Memory will be assessed using the Auditory verbal learning test-Huashan version (AVLT-H). 12 months
Secondary Attention Attention will be evaluated by Trial Making Test (TMT). 12 months
Secondary Executive functions Executive functions will be evaluated by the Stroop task. 12 months
Secondary Language Language will be assessed by Boston naming test (30-item version). 12 months
Secondary Visual spatial ability and visual memory Visual spatial ability and visual memory will be evaluated by the Rey-Osterrieth complex figure test (CFT). 12 months
Secondary Activities of daily living Activities of daily living will be assessed by Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL). 6 months
Secondary Structural MRI Volume of hippocampus and other specific brain regions 12 months
Secondary Gut microbiota Number of genera and abundence of E.coli in feces and blood 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05273125 - MOBility Disorders Assessment in Patients With Mild COGnitive Disorders
Active, not recruiting NCT04049695 - Improving Cognition After Cancer N/A
Completed NCT05912374 - Adapting a Behavioral Intervention to Accommodate Cognitive Dysfunction in People Who Inject Drugs N/A
Recruiting NCT03977350 - Association Between qEEG Measure and Post-Operative Cognitive Dysfunction (POCD) and Postoperative Delirium (POD)
Not yet recruiting NCT06027632 - Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer N/A
Terminated NCT00754013 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10 Phase 3
Terminated NCT00754052 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17 Phase 3
Completed NCT00719628 - Depth of Anaesthesia and Cognitive Dysfunction N/A
Recruiting NCT05014399 - Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Completed NCT04966455 - Effect of Raisins on Cognitive Function in Healthy Older Adults Phase 3
Recruiting NCT05372159 - Vanderbilt Memory and Aging Project
Completed NCT03243279 - BRS and Outcomes in Cardiothoracic Surgery
Completed NCT04093882 - The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease
Recruiting NCT05732285 - A Pilot Randomized Controlled Trial: CoINTEGRATE N/A
Completed NCT06059768 - Urdu Translation and Psychometric Analysis of Lawton IADLS.
Completed NCT04562662 - Evaluation of mediVR-KAGURA Guided Therapy N/A
Completed NCT04624529 - Validity and Reliability of a Self-evaluation Tool for Cognitive Deficits in the Acute Stage After Stroke
Not yet recruiting NCT04079075 - Multiple Interventions to Prevent Cognitive Decline N/A
Active, not recruiting NCT04638101 - Building the Path to Resilience in Preterm Infants: Mindfulness-based Intervention N/A
Active, not recruiting NCT04556305 - Lifestyle Physical Activity and Cognitive Training Interventions N/A